These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
191 related articles for article (PubMed ID: 27607335)
1. Preoperative Anti-tumor Necrosis Factor Therapy in Patients with Ulcerative Colitis Is Not Associated with an Increased Risk of Infectious and Noninfectious Complications After Ileal Pouch-anal Anastomosis. Zittan E; Milgrom R; Ma GW; Wong-Chong N; OʼConnor B; McLeod RS; MacRae HM; Greenberg GR; Nguyen GC; Croitoru K; Steinhart AH; Cohen Z; Silverberg MS Inflamm Bowel Dis; 2016 Oct; 22(10):2442-7. PubMed ID: 27607335 [TBL] [Abstract][Full Text] [Related]
2. Outcomes of Ileoanal Pouch Anastomosis in Pediatric Ulcerative Colitis Are Worse in the Modern Era: A Time Trend Analysis Outcomes Following Ileal Pouch-Anal Anastomosis in Pediatric Ulcerative Colitis. Runde J; Erondu A; Akiyama S; Traboulsi C; Rai V; Glick LR; Yi Y; Ollech JE; Cohen RD; Skowron KB; Hurst RD; Umanskiy K; Shogan BD; Hyman NH; Rubin MA; Dalal SR; Sakuraba A; Pekow J; Chang EB; Rubin DT Inflamm Bowel Dis; 2022 Sep; 28(9):1386-1394. PubMed ID: 35040964 [TBL] [Abstract][Full Text] [Related]
3. Operative strategy modifies risk of pouch-related outcomes in patients with ulcerative colitis on preoperative anti-tumor necrosis factor-α therapy. Gu J; Remzi FH; Shen B; Vogel JD; Kiran RP Dis Colon Rectum; 2013 Nov; 56(11):1243-52. PubMed ID: 24104999 [TBL] [Abstract][Full Text] [Related]
4. Preoperative infliximab is not associated with an increased risk of short-term postoperative complications after restorative proctocolectomy and ileal pouch-anal anastomosis. Gainsbury ML; Chu DI; Howard LA; Coukos JA; Farraye FA; Stucchi AF; Becker JM J Gastrointest Surg; 2011 Mar; 15(3):397-403. PubMed ID: 21246415 [TBL] [Abstract][Full Text] [Related]
5. Association of Preoperative Anti-Tumor Necrosis Factor Therapy With Adverse Postoperative Outcomes in Patients Undergoing Abdominal Surgery for Ulcerative Colitis. Kulaylat AS; Kulaylat AN; Schaefer EW; Tinsley A; Williams E; Koltun W; Hollenbeak CS; Messaris E JAMA Surg; 2017 Aug; 152(8):e171538. PubMed ID: 28614561 [TBL] [Abstract][Full Text] [Related]
6. Systematic Review With Meta-Analysis: Anti-TNF Therapy in Refractory Pouchitis and Crohn's Disease-Like Complications of the Pouch After Ileal Pouch-Anal Anastomosis Following Colectomy for Ulcerative Colitis. Huguet M; Pereira B; Goutte M; Goutorbe F; Dubois A; Bommelaer G; Buisson A Inflamm Bowel Dis; 2018 Jan; 24(2):261-268. PubMed ID: 29361101 [TBL] [Abstract][Full Text] [Related]
7. Preoperative Clostridium difficile Infection Does Not Affect Pouch Outcomes in Patients with Ulcerative Colitis Who Undergo Ileal Pouch-anal Anastomosis. Lightner AL; Tse CS; Quinn K; Bergquist JR; Enders F; Pendegraft R; Khanna S; Raffals L Inflamm Bowel Dis; 2017 Jul; 23(7):1195-1201. PubMed ID: 28410344 [TBL] [Abstract][Full Text] [Related]
8. Comparison of health-related quality of life and disability in ulcerative colitis patients following restorative proctocolectomy with ileal pouch-anal anastomosis versus anti-tumor necrosis factor therapy. van Gennep S; Sahami S; Buskens CJ; van den Brink GR; Ponsioen CY; D'Hoore A; de Buck van Overstraeten A; van Assche G; Ferrante M; Vermeire S; Bemelman WA; D'Haens GR; Löwenberg M Eur J Gastroenterol Hepatol; 2017 Mar; 29(3):338-344. PubMed ID: 27902515 [TBL] [Abstract][Full Text] [Related]
9. Equivalent function, quality of life and pouch survival rates after ileal pouch-anal anastomosis for indeterminate and ulcerative colitis. Delaney CP; Remzi FH; Gramlich T; Dadvand B; Fazio VW Ann Surg; 2002 Jul; 236(1):43-8. PubMed ID: 12131084 [TBL] [Abstract][Full Text] [Related]
10. Health-related quality of life and disability in patients with ulcerative colitis and proctocolectomy with ileoanal pouch versus treatment with anti-TNF agents. Meijs S; Gardenbroek TJ; Sprangers MA; Bemelman WA; Buskens CJ; D'Haens GR; Löwenberg M J Crohns Colitis; 2014 Jul; 8(7):686-92. PubMed ID: 24418659 [TBL] [Abstract][Full Text] [Related]
11. Long-term quality of life associated with early surgical complications in patients with ulcerative colitis after ileal pouch-anal anastomosis: A single-center retrospective study. Xu W; Ye H; Zhu Y; Ding W; Fu J; Cui L; Du P Int J Surg; 2017 Dec; 48():174-179. PubMed ID: 29104126 [TBL] [Abstract][Full Text] [Related]
12. Similar functional results and complications after ileal pouch-anal anastomosis in patients with indeterminate vs ulcerative colitis. Dayton MT; Larsen KR; Christiansen DD Arch Surg; 2002 Jun; 137(6):690-4; discussion 694-5. PubMed ID: 12049540 [TBL] [Abstract][Full Text] [Related]
13. Preoperative exposure to anti-tumor necrosis factor therapy in ulcerative colitis patients undergoing ileal pouch-anal anastomosis (IPAA) is not associated with histological fibrosis: A case control study. Zittan E; Muir J; Milgrom R; Berns M; Gralnek IM; Cohen Z; Riddell R; Silverberg MS Int J Surg; 2019 May; 65():80-85. PubMed ID: 30926567 [TBL] [Abstract][Full Text] [Related]
15. Previous infliximab therapy and postoperative complications after proctocolectomy with ileum pouch anal anastomosis. Eshuis EJ; Al Saady RL; Stokkers PC; Ponsioen CY; Tanis PJ; Bemelman WA J Crohns Colitis; 2013 Mar; 7(2):142-9. PubMed ID: 22542056 [TBL] [Abstract][Full Text] [Related]
16. Ileorectal anastomosis in comparison with ileal pouch anal anastomosis in reconstructive surgery for ulcerative colitis--a single institution experience. Andersson P; Norblad R; Söderholm JD; Myrelid P J Crohns Colitis; 2014 Jul; 8(7):582-9. PubMed ID: 24315777 [TBL] [Abstract][Full Text] [Related]
17. Survival of ileal pouch anal anastomosis constructed after colectomy or secondary to a previous ileorectal anastomosis in ulcerative colitis patients: a population-based cohort study. Landerholm K; Abdalla M; Myrelid P; Andersson RE Scand J Gastroenterol; 2017 May; 52(5):531-535. PubMed ID: 28102092 [TBL] [Abstract][Full Text] [Related]
18. Anti-TNF and Pouch Surgery for Ulcerative Colitis: The Ones who Blame for More Complications? Bislenghi G; Ferrante M; D'Hoore A Curr Drug Targets; 2019; 20(13):1349-1355. PubMed ID: 30919776 [TBL] [Abstract][Full Text] [Related]